Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 64 peer-reviewed journal articles Updated
Rheumatology

Validation & Orientation: Understanding Your APS Diagnosis

At a Glance

Antiphospholipid Syndrome (APS), also known as Hughes Syndrome, is a manageable autoimmune condition that increases the risk of blood clots and pregnancy complications. By understanding triggers and using medications like blood thinners, patients can effectively manage risks and live active lives.

A diagnosis of Antiphospholipid Syndrome (APS) often comes as a shock. You may have heard it called Hughes Syndrome (named after the doctor who first identified it) or simply sticky blood [1][2]. While the name sounds complex, APS is a systemic autoimmune disorder—a condition where your immune system, which usually protects you, mistakenly creates antibodies that attack healthy proteins in your blood [1][2].

It is completely normal to feel overwhelmed, anxious, or even frustrated when diagnosed with this rare but well-understood condition [3]. This guide is designed to help you ground yourself in the facts and understand that while APS is a lifelong condition, it is a manageable one [4].

Understanding the “Two-Hit” Model

To understand how APS works, doctors often use the two-hit model. Think of it like a safety switch on a machine:

  1. The First Hit: This is the presence of the antibodies in your blood. These antibodies “prime” your system, making your blood more likely to clot, but they don’t always cause a clot on their own [5][6].
  2. The Second Hit: This is a specific trigger—such as surgery, an infection, or prolonged immobility—that “flips the switch” and causes a blood clot to actually form [5][7].

By managing your “first hit” with medication and being mindful of “second hit” triggers, you and your doctor can work together to keep the “switch” in the off position.

Two Ways APS Shows Up

APS is generally categorized into two main types, though some people may experience both:

  • Vascular (Thrombotic) APS: This variant involves the formation of blood clots (thrombosis) in the veins (like a DVT in the leg) or arteries (which can lead to a stroke or heart attack) [1][8].
  • Obstetric APS: This variant specifically affects pregnancy. The antibodies can interfere with how the placenta attaches and grows, which may lead to complications like recurrent miscarriages or high blood pressure during pregnancy (preeclampsia) [9][10].

Reassuring Facts for Your Journey

While an APS diagnosis is significant, there are several stabilizing facts to keep in mind:

  • You Are Not Alone: Despite its rarity, there is a global community of patients and researchers dedicated to improving care and outcomes [11].
  • Treatment is Effective: Most people with APS live full, active lives by using anticoagulants (blood thinners) or medications like hydroxychloroquine to prevent clots and manage inflammation [4][12].
  • Healthy Pregnancies are Possible: With the help of specialists, many women with obstetric APS go on to have successful pregnancies and healthy babies using treatments like aspirin and heparin [13][14].
  • Proactive Cardiovascular Care: While APS does increase your risk for cardiovascular issues, this risk is highly manageable. By actively working with your doctor to control factors like blood pressure and cholesterol, you can effectively protect your heart [15].
  • Knowledge is Protective: Early recognition and proper treatment are the most powerful tools for preventing future complications and ensuring a positive long-term outlook [16].

Please explore the following sections of this guide to learn more about the Symptoms, Subtypes, and the Biology of APS, how to understand Diagnosis, The 12-Week Rule, and Understanding Your Labs, your options for Standard of Care Treatment: Warfarin, Heparin, and DOACs, and navigating Living with APS, Survivorship, and Monitoring.

In this guide

4 chapters

01

Symptoms, Subtypes, and the Biology of APS

Learn about Antiphospholipid Syndrome (APS) symptoms, blood clots, and pregnancy risks. Understand primary vs. secondary APS and CAPS warning signs.

02

Diagnosis, The 12-Week Rule, and Understanding Your Labs

Learn how Antiphospholipid Syndrome (APS) is diagnosed. Understand the 12-week rule, triple positivity, and what your LA, aCL, and aB2GPI lab results mean.

03

Standard of Care Treatment: Warfarin, Heparin, and DOACs

Learn about standard treatments for Antiphospholipid Syndrome (APS). Understand why Warfarin is preferred over DOACs, and how Heparin protects pregnancies.

04

Living with APS, Survivorship, and Monitoring

Learn how to manage Antiphospholipid Syndrome (APS) in your daily life. Discover tips for INR monitoring, managing brain fog, and preventing blood clots.

Common questions in this guide

What is the two-hit model in Antiphospholipid Syndrome?
The 'two-hit' model explains how APS causes blood clots. The first hit is the presence of APS antibodies in your blood, and the second hit is a specific trigger, like surgery or an infection, that actually causes the clot to form.
What is the difference between vascular and obstetric APS?
Vascular APS involves blood clots forming in your veins or arteries, which can lead to issues like deep vein thrombosis or strokes. Obstetric APS specifically affects pregnancy, potentially causing complications like recurrent miscarriages or preeclampsia.
Can I have a healthy pregnancy if I am diagnosed with APS?
Yes, many women with obstetric APS have successful pregnancies and healthy babies. By working closely with specialists and using treatments like aspirin and heparin, pregnancy risks can be effectively managed.
What triggers or lifestyle factors should I avoid with APS?
Triggers for blood clots, often called the 'second hit', can include prolonged immobility, infections, and certain surgeries. It is important to discuss your specific lifestyle and medical triggers with your doctor to help keep your blood clot risk low.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my blood work, am I considered 'high risk' for a future blood clot?
  2. 2.Do I have vascular APS, obstetric APS, or both, and how does that change my treatment plan?
  3. 3.What are my 'second hit' triggers (like certain medications or lifestyle factors) that I should specifically avoid?
  4. 4.If I want to have a child in the future, what steps do we need to take now to prepare?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Added value of antiphosphatidylserine/prothrombin antibodies in the workup of thrombotic antiphospholipid syndrome: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies.

    Vandevelde A, Chayoua W, de Laat B, et al.

    Journal of thrombosis and haemostasis : JTH 2022; (20(9)):2136-2150 doi:10.1111/jth.15785.

    PMID: 35713971
  2. 2

    Antiphospholipid syndrome.

    Petri M

    Translational research : the journal of laboratory and clinical medicine 2020; (225()):70-81 doi:10.1016/j.trsl.2020.04.006.

    PMID: 32413497
  3. 3

    The New Occurrence of Antiphospholipid Syndrome in Severe COVID-19 Cases with Pneumonia and Vascular Thrombosis Could Explain the Post-COVID Syndrome.

    Zlatković-Švenda M, Rašić M, Ovuka M, et al.

    Biomedicines 2025; (13(2)) doi:10.3390/biomedicines13020516.

    PMID: 40002929
  4. 4

    HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

    Belizna C, Pregnolato F, Abad S, et al.

    Autoimmunity reviews 2018; (17(12)):1153-1168 doi:10.1016/j.autrev.2018.05.012.

    PMID: 30316994
  5. 5

    Antiphospholipid syndrome in pregnancy: a comprehensive literature review.

    Murvai VR, Galiș R, Panaitescu A, et al.

    BMC pregnancy and childbirth 2025; (25(1)):337 doi:10.1186/s12884-025-07471-w.

    PMID: 40128683
  6. 6

    Antiphospholipid Syndrome and Kidney Involvement.

    De Simone E, Sciascia S, Fenoglio R, et al.

    Kidney & blood pressure research 2023; (48(1)):666-677 doi:10.1159/000529229.

    PMID: 37734329
  7. 7

    Precipitating factors of catastrophic antiphospholipid syndrome: the role of anticoagulant treatment in a series of 112 patients.

    Stammler R, Nguyen Y, Yelnik C, et al.

    Journal of thrombosis and haemostasis : JTH 2023; (21(5)):1258-1265 doi:10.1016/j.jtha.2023.02.007.

    PMID: 36792010
  8. 8

    Understanding antiphospholipid syndrome clinical phenotypes with the guidance of antiphospholipid antibody-related pathogenic mechanisms.

    Sevim E, Erton ZB, Erkan D

    Current opinion in immunology 2026; (100()):102770 doi:10.1016/j.coi.2026.102770.

    PMID: 42013510
  9. 9

    Obstetric and vascular antiphospholipid syndrome: same antibodies but different diseases?

    Meroni PL, Borghi MO, Grossi C, et al.

    Nature reviews. Rheumatology 2018; (14(7)):433-440 doi:10.1038/s41584-018-0032-6.

    PMID: 29891914
  10. 10

    Trophoblast Cell Function in the Antiphospholipid Syndrome.

    Vrzić Petronijević S, Vilotić A, Bojić-Trbojević Ž, et al.

    Biomedicines 2023; (11(10)) doi:10.3390/biomedicines11102681.

    PMID: 37893055
  11. 11

    Do ethnoracial differences exist among antiphospholipid antibody-positive patients with no other systemic autoimmune diseases: results from the APS ACTION registry.

    Gkrouzman E, Matijasevich A, Bonilla Richero C, et al.

    Advances in rheumatology (London, England) 2026; (66(1)).

    PMID: 41992377
  12. 12

    Type I interferon gene expression in antiphospholipid syndrome: Pathogenetic, clinical and therapeutic implications.

    Xourgia E, Tektonidou MG

    Journal of autoimmunity 2019; (104()):102311 doi:10.1016/j.jaut.2019.102311.

    PMID: 31378637
  13. 13

    Investigating the association between antiphospholipid syndrome and ovarian reserve: A systematic review and meta-analysis of the literature.

    Hemmati N, Sahebari M, Larki M, et al.

    Lupus 2025; (34(6)):588-596 doi:10.1177/09612033251332051.

    PMID: 40167107
  14. 14

    Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature.

    Urban ML, Bettiol A, Serena C, et al.

    Autoimmunity reviews 2020; (19(9)):102620 doi:10.1016/j.autrev.2020.102620.

    PMID: 32682986
  15. 15

    Left Ventricle Libman-Sacks Endocarditis Secondary to Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report.

    Yang ZH, Gong WQ, Liu Y, Zheng MJ

    The American journal of case reports 2025; (26()):e949826 doi:10.12659/AJCR.949826.

    PMID: 41129477
  16. 16

    Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female.

    Jamal F, Kumar R, Hakobyan N

    Cureus 2024; (16(7)):e64856 doi:10.7759/cureus.64856.

    PMID: 39156266

This page provides general educational information about diagnosing and understanding Antiphospholipid Syndrome (APS). It does not replace professional medical advice, diagnosis, or treatment from your healthcare provider.

Get notified when new evidence is published on Antiphospholipid syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.